Advertisement

Current Psychiatry Reports

, Volume 14, Issue 3, pp 229–236 | Cite as

Functional Outcomes in Schizophrenia: Employment Status as a Metric of Treatment Outcome

  • Rebecca Schennach
  • Richard Musil
  • Hans-Jürgen Möller
  • Michael Riedel
SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS (SJ SIEGEL, SECTION EDITOR)

Abstract

The importance of an adequate and satisfying level of functioning for the course and outcome of schizophrenia has been increasingly emphasized by researchers in recent years. Employment status is a major component of the patient’s functioning and is generally believed to be essential for well-being, satisfaction in life, and a better prognosis for schizophrenia illness. This article summarizes recent relevant publications concerning the employment status of schizophrenia patients and its influence on treatment outcome. Given the significant link between employment status and outcome in schizophrenia, different influencing factors of employment are discussed, as they mirror potential treatment targets. Finally, currently available treatment strategies for the improvement of employment status are outlined.

Keywords

Schizophrenia Outcome Symptomatic remission Functioning Recovery Employment Employment status Influencing factors Vocational rehabilitation Atypical antipsychotics Treatment Treatment outcome Cognitive remediation 

Notes

Disclosure

Dr. Musil has had travel/accommodations expenses covered/reimbursed by AstraZeneca and Eli Lilly and Company.

Dr. Schennach and Prof. Riedel reported no potential conflicts of interest relevant to this article.

Prof. Möller has received grants or is a consultant for and on the speakership bureaus of AstraZeneca, Bristol-Myers-Squibb, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck, Merck, Novartis, Organon, Pfizer, Sanofi-Aventis, Schering-Plough, Schwabe, Sepracor, Servier and Wyeth.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Kraepelin E. Dementia praecox and paraphrenia. Edinburgh: Livingstone; 1919.Google Scholar
  2. 2.
    Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PW, Leon CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry. 2001;178:506-17–506-517.PubMedCrossRefGoogle Scholar
  3. 3.
    Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004;161(3):473–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Andreasen NC, Carpenter Jr WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441–9.PubMedCrossRefGoogle Scholar
  5. 5.
    • Karow A, Moritz S, Lambert M, Schottle D, Naber D. Remitted but still impaired? symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatr. 2011. This was one of the first studies to explicitly compare symptomatic improvement (via the consensus remission criteria) and patient level of functioning. Google Scholar
  6. 6.
    Schennach-Wolff R, Jager M, Seemuller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Ruther E, Buchkremer G, Gastpar M, Moller HJ, Riedel M. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res. 2009.Google Scholar
  7. 7.
    Möller HJ, Jäger M, Riedel M, Obermeier M, Strauss A, Bottlender R. The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci. 2010;260(5):367–84.Google Scholar
  8. 8.
    Davidson L, Lawless MS, Leary F. Concepts of recovery: competing or complementary? Curr Opin Psychiatr. 2005;18(6):664–7.CrossRefGoogle Scholar
  9. 9.
    Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophr Bull. 2009.Google Scholar
  10. 10.
    Liberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv. 2005;56(6):735–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Bachmann S, Bottmer C, Schroder J. One-year outcome and its prediction in first-episode schizophrenia—a naturalistic study. Psychopathology. 2008;41(2):115–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P, Wooff K. Long-term course of hospitalization for schizophrenia: part I. Risk for rehospitalization. Schizophr Bull. 1992;18(2):217–28.PubMedGoogle Scholar
  13. 13.
    Noordsy DL, Torrey WC, Mueser KT, Mead S, O'Keefe CO, Fox L. Recovery from severe mental illness: an interpersonal and functional outcome definition. Int Rev Psychiatr. 2002;14318–326.Google Scholar
  14. 14.
    Liberman R, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatr. 2002;4256–272.Google Scholar
  15. 15.
    Habich R, Noll HH. Objektive lebensbedingungen und subjektives Wohlbefinden im vereinten Deutschland. Datenreport 1994. 1994. Statistisches Bundesamt.Google Scholar
  16. 16.
    Harding CM, Strauss JS, Hafez H, Lieberman PB. Work and mental illness. I. Toward an integration of the rehabilitation process. J Nerv Ment Dis. 1987;175(6):317–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Warner R. Recovery from schizophrenia. Psychiatry and political economy. Brunner-Routledge; 2004.Google Scholar
  18. 18.
    Brown GW. CGM&TG: post-hospital adjustment of chronic mental patients. Lancet. 1958;2685–689.Google Scholar
  19. 19.
    Dunn EC, Wewiorski NJ, Rogers ES. The meaning and importance of employment to people in recovery from serious mental illness: results of a qualitative study. Psychiatr Rehabil J. 2008;32(1):59–62.PubMedCrossRefGoogle Scholar
  20. 20.
    Krupa T. Employment, recovery, and schizophrenia: integrating health and disorder at work. Psychiatr Rehabil J. 2004;28(1):8–15.PubMedCrossRefGoogle Scholar
  21. 21.
    Ucok A, Gorwood P, Karadayi G. Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study. Eur Psychiatr. 2011.Google Scholar
  22. 22.
    Priebe S, Warner R, Hubschmid T, Eckle I. Employment, attitudes toward work, and quality of life among people with schizophrenia in three countries. Schizophr Bull. 1998;24(3):469–77.PubMedCrossRefGoogle Scholar
  23. 23.
    Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, Huber CG, Suarez D, Haro JM, Novick D, Dittmann RW, Schimmelmann BG. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand. 2008;118(3):220–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Kilian R, Lauber C, Kalkan R, Dorn W, Rossler W, Wiersma D, van Buschbach JT, Fioritti A, Tomov T, Catty J, Burns T, Becker T. The relationships between employment, clinical status, and psychiatric hospitalisation in patients with schizophrenia receiving either IPS or a conventional vocational rehabilitation programme. Soc Psychiatr Psychiatr Epidemiol. 2011.Google Scholar
  25. 25.
    Schennach R, Riedel M, Obermeier M, Jager M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkotter J, Heuser I, Maier W, Lemke MR, Ruther E, Klingberg S, Gastpar M, Seemuller F, Moller HJ. Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial. Psychiatr Q. 2011.Google Scholar
  26. 26.
    Novick D, Haro JM, Suarez D, Vieta E, Naber D. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophr Res. 2009;108(1–3):223–30.PubMedCrossRefGoogle Scholar
  27. 27.
    Schennach R, Obermeier M, Meyer S, Jager M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkotter J, Heuser I, Maier W, Lemke MR, Ruther E, Klingberg S, Gastpar M, Seemuller F, Moller HJ, Riedel M. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2012;63(1):87–90.PubMedCrossRefGoogle Scholar
  28. 28.
    Chabungbam G, Avasthi A, Sharan P. Sociodemographic and clinical factors associated with relapse in schizophrenia. Psychiatr Clin Neurosci. 2007;61(6):587–93.CrossRefGoogle Scholar
  29. 29.
    Shrivastava A, Shah N, Johnston M, Stitt L, Thakar M. Predictors of long-term outcome of first-episode schizophrenia: a ten-year follow-up study. Indian J Psychiatr. 2010;52(4):320–6.CrossRefGoogle Scholar
  30. 30.
    Gaite L, Vazquez-Barquero JL, Borra C, Ballesteros J, Schene A, Welcher B, Thornicroft G, Becker T, Ruggeri M, Herran A. Quality of life in patients with schizophrenia in five European countries: the EPSILON study. Acta Psychiatr Scand. 2002;105(4):283–92.PubMedCrossRefGoogle Scholar
  31. 31.
    Tsang HW, Leung AY, Chung RC, Bell M, Cheung WM. Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust N Z J Psychiatry. 2010;44(6):495–504.PubMedGoogle Scholar
  32. 32.
    Mueser KT, Salyers MP, Mueser PR. A prospective analysis of work in schizophrenia. Schizophr Bull. 2001;27(2):281–96.PubMedCrossRefGoogle Scholar
  33. 33.
    Marwaha S, Johnson S, Bebbington P, Stafford M, Angermeyer MC, Brugha T, Azorin JM, Kilian R, Hansen K, Toumi M. Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry. 2007;191:30-7–30-37.PubMedCrossRefGoogle Scholar
  34. 34.
    Ucok A, Serbest S, Kandemir PE. Remission after first-episode schizophrenia: results of a long-term follow-up. Psychiatr Res. 2011;189(1):33–7.CrossRefGoogle Scholar
  35. 35.
    Lysaker P, Bell M. Negative symptoms and vocational impairment in schizophrenia: repeated measurements of work performance over 6 months. Acta Psychiatr Scand. 1995;91(3):205–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Albert N, Bertelsen M, Thorup A, Petersen L, Jeppesen P, Le QP, Krarup G, Jorgensen P, Nordentoft M. Predictors of recovery from psychosis analyses of clinical and social factors associated with recovery among patients with first-episod psychosis after 5 years. Schizophr Res. 2011;125(2–3):257–66.PubMedCrossRefGoogle Scholar
  37. 37.
    Erickson M, Jaafari N, Lysaker P. Insight and negative symptoms as predictors of functioning in a work setting in patients with schizophrenia. Psychiatr Res. 2011;189(2):161–5.CrossRefGoogle Scholar
  38. 38.
    Giugiario M, Crivelli B, Mingrone C, Montemagni C, Scalese M, Sigaudo M, Rocca G, Rocca P. Cognitive function and competitive employment in schizophrenia: relative contribution of insight and psychopathology. Soc Psychiatr Psychiatr Epidemiol. 2011.Google Scholar
  39. 39.
    Palmer BW, Dawes SE, Heaton RK. What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev. 2009;19(3):365–84.PubMedCrossRefGoogle Scholar
  40. 40.
    Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull. 2000;26(1):119–36.PubMedCrossRefGoogle Scholar
  41. 41.
    McGurk SR. Neurocognition as a determinant of employment status in schizophrenia. J Psychiatr Pract. 2000;6(4):190–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, Miller AL. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res. 1997;25(1):21–31.PubMedCrossRefGoogle Scholar
  43. 43.
    Kurtz MM. Neurocognition as a predictor of response to evidence-based psychosocial interventions in schizophrenia: what is the state of the evidence? Clin Psychol Rev. 2011;31(4):663–72.PubMedCrossRefGoogle Scholar
  44. 44.
    •• Tandberg M, Ueland T, Sundet K, Haahr U, Joa I, Johannessen JO, Larsen TK, Opjordsmoen S, Rund BR, Rossberg JI, Simonsen E, Vaglum P, Melle I, Friis S, McGlashan T. Neurocognition and occupational functioning in patients with first-episode psychosis: a 2-year follow-up study. Psychiatr Res. 2011;188(3):334–342. This is one of the few very recent studies to focus on occupational functioning and one of its most important influencing factors, neurocognition. It examined a time period of 2 years. CrossRefGoogle Scholar
  45. 45.
    • Hofer A, Bodner T, Kaufmann A, Kemmler G, Mattarei U, Pfaffenberger NM, Rettenbacher MA, Trebo E, Yalcin N, Fleischhacker WW. Symptomatic remission and neurocognitive functioning in patients with schizophrenia. Psychol Med. 2011;1–9. This was a very well-performed analysis evaluating the link among psychopathological symptoms, neurocognition, and occupational functioning. Google Scholar
  46. 46.
    Muller P, Gaebel W, Bandelow B, Kopcke W, Linden M, Muller-Spahn F, Pietzcker A, Tegeler J. The social status of schizophrenic patients. Nervenarzt. 1998;69(3):204–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Wagner LC, Torres-Gonzalez F, Geidel AR, King MB. Existential questions in schizophrenia: perception of patients and caregivers. Rev Saude Publica. 2011;45(2):401–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Bond GR, Becker DR, Drake RE, Rapp CA, Meisler N, Lehman AF, Bell MD, Blyler CR. Implementing supported employment as an evidence-based practice. Psychiatr Serv. 2001;52(3):313–22.PubMedCrossRefGoogle Scholar
  49. 49.
    Cook JA, Razzano L. Vocational rehabilitation for persons with schizophrenia: recent research and implications for practice. Schizophr Bull. 2000;26(1):87–103.PubMedCrossRefGoogle Scholar
  50. 50.
    Twamley EW, Jeste DV, Lehman AF. Vocational rehabilitation in schizophrenia and other psychotic disorders: a literature review and meta-analysis of randomized controlled trials. J Nerv Ment Dis. 2003;191(8):515–23.PubMedCrossRefGoogle Scholar
  51. 51.
    Lehman AF, Steinwachs DM. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24(1):1–10.PubMedCrossRefGoogle Scholar
  52. 52.
    Young KA. Working toward recovery in New Hampshire: a study of modernized vocational rehabilitation from the viewpoint of the consumer. Psychiatr Rehabil J. 2001;24(4):355–67.PubMedGoogle Scholar
  53. 53.
    Corrigan P, Mueser KT, Bond GR, Drake RE, Solomon P. The principle and practice of psychiatric rehabilitation: an empirical approach. New York: Guilford; 2008.Google Scholar
  54. 54.
    Becker DR, Drake RE. A working life: the Individual Placement Support (IPS) program. Psychiatric Research Center New Hampshire-Dartmouth; 1993.Google Scholar
  55. 55.
    Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia. World J Biol Psychiatr. 2005;6(3):132–91.CrossRefGoogle Scholar
  56. 56.
    Lindstrom L, Lundberg T. Long-term effect on outcome of clozapine in chronic therapy-resistant schizophrenic patients. Eur Psychiatr. 1997;12 Suppl 5:353s-5s–353s-355s.Google Scholar
  57. 57.
    Littrell K. Maximizing schizophrenia treatment outcomes: a model for integration. Psychiatr Rehabil J. 1995;1975–77.Google Scholar
  58. 58.
    Noordsy DL, O'Keefe C, Mueser KT, Xie H. Six-month outcomes for patients who switched to olanzapine treatment. Psychiatr Serv. 2001;52(4):501–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Noordsy DL, O'Keefe C. Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a community mental health center setting. J Clin Psychiatr. 1999;19(60 Suppl):47–51. discussion 52-3.47-51.Google Scholar
  60. 60.
    Meyer PS, Bond GR, Tunis SL, McCoy ML. Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program. J Clin Psychiatr. 2002;63(2):108–16.CrossRefGoogle Scholar
  61. 61.
    Bond GR, Kim HW, Meyer PS, Gibson PJ, Tunis S, Evans JD, Lysaker P, McCoy ML, Dincin J, Xie H. Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics. Psychiatr Serv. 2004;55(1):59–66.PubMedCrossRefGoogle Scholar
  62. 62.
    McGurk SR, Mueser KT, DeRosa TJ, Wolfe R. Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr Bull. 2009;35(2):319–35.PubMedCrossRefGoogle Scholar
  63. 63.
    Barlati S, De PL, Deste G, Fusar-Poli P, Vita A. Cognitive remediation in the early course of schizophrenia: a critical review. Curr Pharmaceut Des. 2012.Google Scholar
  64. 64.
    Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168(5):472–85.PubMedCrossRefGoogle Scholar
  65. 65.
    •• Wykes T, Spaulding WD. Thinking about the future cognitive remediation therapy—what works and could we do better? Schizophr Bull. 2011;37(Suppl 2):S80-90–S80-S90. This is a relevant review of current knowledge on cognitive remediation, which is a major therapeutic strategy in supporting patient employment status. PubMedCrossRefGoogle Scholar
  66. 66.
    Wexler BE, Bell MD. Cognitive remediation and vocational rehabilitation for schizophrenia. Schizophr Bull. 2005;31(4):931–41.PubMedCrossRefGoogle Scholar
  67. 67.
    Kozma C, Dirani R, Canuso C, Mao L. Change in employment status over 52 weeks in patients with schizophrenia: an observational study. Curr Med Res Opin. 2011;27(2):327–33.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Rebecca Schennach
    • 1
  • Richard Musil
    • 1
  • Hans-Jürgen Möller
    • 1
  • Michael Riedel
    • 1
    • 2
  1. 1.Department of Psychiatry and PsychotherapyLudwig-Maximilians-University MunichMunichGermany
  2. 2.Psychiatric ClinicVinzenz-von-Paul-HospitalRottweilGermany

Personalised recommendations